Investment in the health and pharmaceutical industry saw robust growth in China in recent few years. In 2019, there were 88 investment deals completed by the private equity financial buyers in the pharmaceutical sector in China, while there were 99 deals by venture capital financial buyers.
Number of financial buyer deals in the pharmaceutical sector in China between 2016 and 2019, by funding method
Characteristic
Private equity
Venture capital
2019
88
99
2018
86
129
2017
39
39
2016
53
38
Loading statistic...
Download
Sources
PwC; Thomson Reuters; Various sources (ChinaVenture)
Survey by
PwC; Thomson Reuters; Various sources (ChinaVenture)
The deal volume figures refer to the number of deals announced, regardless of whether or not a value is disclosed for the deal.
Financial buyer refers to investors that acquire companies with the objective of realizing a return on their investment by selling the business as a profit at a future date and mainly, but not entirely, comprise private equity (PE) and venture capital (VC) funds.
Private equity (PE) deals refer to financial buyers deal with deal value over ten million U.S. dollars and/or with undisclosed deal value, invested mainly by private equity GPs but also including direct investments by financial institutions and conglomerates which are of the nature of private equity type investment.
Venture capital (VC) deals refer to financial buyer deals with deal value of less than U.S ten million and/or with undisclosed deal, but invested by venture capital funds.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
PwC. (April 15, 2020). Number of financial buyer deals in the pharmaceutical sector in China between 2016 and 2019, by funding method [Graph]. In Statista. Retrieved November 13, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1112715/china-financial-buyer-pharmaceutical-deals-by-funding-method/
PwC. "Number of financial buyer deals in the pharmaceutical sector in China between 2016 and 2019, by funding method." Chart. April 15, 2020. Statista. Accessed November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1112715/china-financial-buyer-pharmaceutical-deals-by-funding-method/
PwC. (2020). Number of financial buyer deals in the pharmaceutical sector in China between 2016 and 2019, by funding method. Statista. Statista Inc.. Accessed: November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1112715/china-financial-buyer-pharmaceutical-deals-by-funding-method/
PwC. "Number of Financial Buyer Deals in The Pharmaceutical Sector in China between 2016 and 2019, by Funding Method." Statista, Statista Inc., 15 Apr 2020, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1112715/china-financial-buyer-pharmaceutical-deals-by-funding-method/
PwC, Number of financial buyer deals in the pharmaceutical sector in China between 2016 and 2019, by funding method Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1112715/china-financial-buyer-pharmaceutical-deals-by-funding-method/ (last visited November 13, 2024)
Number of financial buyer deals in the pharmaceutical sector in China between 2016 and 2019, by funding method [Graph], PwC, April 15, 2020. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1112715/china-financial-buyer-pharmaceutical-deals-by-funding-method/
